Second Treatment Effective for Peritoneal Mesothelioma
There is some good news from the Wake Forest School of Medicine for patients with peritoneal mesothelioma. In many cases, after…
-
-
Immunotherapy for Mesothelioma Shows Promise
Despite the continuing efforts of researchers around the world, there is currently no standardized cure for mesothelioma. The asbestos-linked cancer… -
Surgery | Treatments | Updates
Mesothelioma Study: Quality of Life “Acceptable” with Pneumonectomy
Mesothelioma patients who undergo lung removal surgery (pneumonectomy) can still enjoy an acceptable quality of life, in spite of the risks… -
Immunotherapy May Improve Chemotherapy for Mesothelioma
A treatment designed to inhibit a cell protein called CTLA-4 may improve the effectiveness of chemotherapy for mesothelioma. Chemotherapy is… -
High Dose Radiation: Viable for Mesothelioma?
Radiation therapy may be a better option for mesothelioma than it used to be – especially when it is delivered using advanced… -
Surgery | Treatments | Updates
Pleurodesis May Impact Mesothelioma Scan Results
Mesothelioma patients who undergo a procedure called talc pleurodesis (TP) for excess lung fluid may be harder to monitor with FDG-PET/CT… -
Drug Combo Fails to Improve Mesothelioma Survival
Adding the VEGF-inhibitor bevacizumab to a popular chemotherapy combination for mesothelioma does not appear to prolong survival after all. Scientists at 11… -
Orphan Drug Shows Survival Advantage in Mesothelioma
Long-term follow-up on a second-line drug for mesothelioma confirms its potential for prolonging survival. NGR-hTNF is a vascular targeting agent that… -
Effectiveness of Mesothelioma Drug Improved by Other Compounds
Two new studies suggest that a popular mesothelioma drug becomes more effective when combined with other compounds. Pemetrexed (Alimta) is considered… -
Chemotherapy “Bath” May Stop Mesothelioma Spread
There is more evidence that washing heated chemotherapy drugs through the open body cavity after mesothelioma surgery may help stop the cancer…
